29 suspended. 29 Phase 2, 13 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 29 | Suspended 29 |
| Phase 1 | 13 | Suspended 13 |
Follow Hematologic Diseases: new trials by email Literature Review of Hematologic Diseases trials Research Report on Hematologic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pyronaridine in Acute Myeloid Leukemia (AML) Pyronaridine Tetraphosphate - Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Suspended | Armaceutica, Inc. | 200 | 2028-02-21 | 2026-10-19 |
| Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS) Allogeneic umbilical cord mesenchymal stem cells, Decitabine - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Suspended | Sclnow Biotechnology Co., Ltd. | 40 | 2026-12-31 | 2026-04-23 |
| Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma Mirdametinib, Sirolimus - Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma (RRMM) | Phase 1 / Phase 2 | Suspended | National Cancer Institute (NCI) | 54 | 2026-11-23 | 2026-11-18 |
| Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Collection - B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia | Phase 2 | Suspended | University of Washington | 30 | 2026-05-08 | 2026-09-29 |
| ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis Cyclophosphamide, Fludarabine, Thiotepa - Acute Myelogenous Leukemia, Acute Lymphatic Leukemia | Phase 2 | Suspended | Leland Metheny | 20 | 2026-04-08 | 2026-09-10 |
| Ascorbate in Myelodysplastic Syndrome High-dose ascorbate, Azacitidine - Myelodysplastic Syndromes | Phase 2 | Suspended | Prajwal Dhakal | 38 | 2026-03-11 | 2026-10-09 |
| Mozobil for Autologous Hematopoietic Stem Cell Transplantation Plerixafor, Gcsf - Multiple Myeloma, Hodgkin Lymphoma | Phase 2 | Suspended | Thomas Jefferson University | 100 | 2025-10-16 | 2026-11-18 |
| External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Extramedullary Disease in Multiple Myeloma, Multiple Myeloma | Phase 1 / Phase 2 | Suspended | City of Hope Medical Center | 20 | 2025-08-29 | 2026-10-07 |
| Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations Eltrombopag (EPAG) - Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia | Phase 2 | Suspended | Abhay Singh, MD MPH | 25 | 2025-06-17 | 2026-10-09 |
| A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma Brincidofovir - Relapsed or Refractory Lymphoma Including ENKL | Phase 1 / Phase 2 | Suspended | SymBio Pharmaceuticals | 43 | 2025-06-09 | 2026-02-05 |
| Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma Iberdomide, Belantamab Mafodotin, Dexamethasone - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 / Phase 2 | Suspended | Alliance for Clinical Trials in Oncology | 88 | 2025-04-23 | 2026-10-02 |
| Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Multiple Myeloma | Phase 2 | Suspended | National Cancer Institute (NCI) | 84 | 2024-08-27 | 2026-10-19 |
| Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE Dasatinib - Acute Myeloid Leukemia | Phase 2 | Suspended | Institut Paoli-Calmettes | 35 | 2024-05-22 | 2026-10-01 |
| Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma Carfilzomib, Iberdomide, Oral Dexamethasone - Multiple Myeloma | Phase 1 / Phase 2 | Suspended | Hackensack Meridian Health | 66 | 2022-05-13 | 2026-07-13 |
| Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients Lenalidomide, Luspatercept - Myelodysplastic Syndromes | Phase 1 / Phase 2 | Suspended | Mikkael Sekeres, MD | 50 | 2021-11-09 | 2026-07-17 |
| Two Step Haplo With Radiation Conditioning Fludarabine, Total-Body Irradiation, Donor Lymphocyte Infusion - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Suspended | Thomas Jefferson University | 63 | 2021-10-25 | 2026-11-18 |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) fadraciclib - Leukemia, Myelodysplastic Syndrome(MDS) | Phase 1 / Phase 2 | Suspended | Cyclacel Pharmaceuticals, Inc. | 210 | 2021-10-22 | 2024-02-08 |
| Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia IBI188, Azacitidine, Decitabine - Acute Myeloid Leukemia | Phase 1 / Phase 2 | Suspended | Innovent Biologics (Suzhou) Co. Ltd. | 222 | 2020-09-25 | 2023-10-23 |
| Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma NEXI-002 T Cells - Relapsed Refractory Multiple Myeloma | Phase 1 / Phase 2 | Suspended | NexImmune Inc. | 9 | 2020-08-17 | 2024-01-16 |
| Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Emavusertib, Venetoclax - Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 1 / Phase 2 | Suspended | Curis, Inc. | 366 | 2020-07-06 | 2026-03-19 |
Showing 20 of 29. Sign in to see all of them.
Myelodysplastic Syndromes (12) · Leukemia, Myeloid, Acute (9) · Multiple Myeloma (8) · Leukemia (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Hodgkin Disease (3) · Leukemia, Myelomonocytic, Chronic (3) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (3) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Neoplasms (2) · Primary Myelofibrosis (2) · Recurrence (2)
Hemic and Lymphatic Diseases (29) · Neoplasms by Histologic Type (24) · Neoplasms (22) · Immune System Diseases (16) · Immunoproliferative Disorders (15) · Lymphoproliferative Disorders (15) · Leukemia (13) · Bone Marrow Diseases (12) · Leukemia, Myeloid (10) · Lymphatic Diseases (9) · Blood Protein Disorders (8) · Cardiovascular Diseases (8) · Hemorrhagic Disorders (8) · Hemostatic Disorders (8)
Magnetic Resonance Spectroscopy (4) · Specimen Handling (4) · Biopsy (3) · Cyclophosphamide (3) · iberdomide (3) · Ascorbic Acid (2) · Azacitidine (2) · Decitabine (2) · Dexamethasone (2) · Filgrastim (2) · Granulocyte Colony-Stimulating Factor (2) · Mycophenolic Acid (2) · Tacrolimus (2) · Whole-Body Irradiation (2) · X-Rays (2)
National Cancer Institute (NCI) (2) · Thomas Jefferson University (2) · Abhay Singh, MD MPH (1) · Alliance for Clinical Trials in Oncology (1) · Armaceutica, Inc. (1) · BioMAS Ltd (1) · City of Hope Medical Center (1) · Curis, Inc. (1) · Cyclacel Pharmaceuticals, Inc. (1) · Hackensack Meridian Health (1) · Humanigen, Inc. (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Institut Paoli-Calmettes (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · Leland Metheny (1)
United States (16) · China (5) · France (2) · Israel (2) · Australia (1) · Canada (1) · Czechia (1) · Germany (1) · Italy (1) · Japan (1) · Mexico (1) · Poland (1) · Senegal (1) · Singapore (1) · South Korea (1)
Abhay Singh, MD, MPH (1) · Elizabeth M Hill, M.D. (1) · Jiong HU, M.D., (1) · Juan Sierra-Madero, MD (1) · Jun Zhu, M.D. (1) · Kristi Jones (1) · Lei Guo (1) · Leland Metheny, MD (1) · Mikkael Sekeres, MD (1) · Mitchell Sabloff (1) · Morgan Lam (1) · Moshe Gatt, MD (1) · Noa Biran, MD (1) · Prajwal Dhakal, MD (1) · Renato J Aguilera, PhD (1)
PMID 12628464, PMID 14557216, PMID 16249702, PMID 17273548, PMID 19284416, PMID 19645607, PMID 20651586, PMID 21403129, PMID 21921156, PMID 22632127, PMID 27736729, PMID 29093707, PMID 9204894, PMID 9461195
P30CA033572 (1), U10CA180821 (1)